Questions discussed in this category
Would you recommend avoiding estrogen-containing OCPs?
Would you test for APLS to evaluate for additional thrombotic risk factors? While not heredita...
How would your recommendation change if the patient has H63 homozygous mutation?
For example, in a patient with ongoing GI bleeding already on monthly IV iron dextran 1000 mg, would you consider dosing more frequently at Q2 or Q3 w...
How often does this occur and does this lower your suspicion for a "true" or clinically significant lupus anticoagulant?
Do you consider starting Ursodiol? Do you perform routine abdominal ultrasound to monitor for cholelithiasis?
Would you consider chronic RBC exchange versus HU?
Are there specific guidelines for managing this patient population?
Do you do additional workup for venous obstruction or any other different testing/evaluation?
Does this hold true when the patient has significant inflammation?
Ferritin >2200, TSAT >80%
There are various formulations of intravenous iron; each with varying costs, test dose requirement, elemental dose, and number or time of infusions ne...
Common thought is that FVIII may be used for differentiating coagulopathy in liver disease (normal to increased, from reduced clearance of VWF/FVIII) ...
I.e. platelet count <30. Would your management change if HIT were only suspected rather than confirmed?
E.g. Normal F8, VWF activity ~50%, VWF antigen ~100%, ratio 0.5 sent in a patient with positive bleeding history
Is there any clinical significance t...
Specifically, asymptomatic subsegmental PE diagnosed within a month from planned bilateral mastectomy for breast cancer.
Provided that the platelet count is normal, do you usually consider this to be a potential erroneous result or do you pursue additional workup for RBC...
How often do you see non transfusion-dependent thalassemia and how do you approach the treatment?
Although TIBC is negative acute phase reactant, would it be a better indicator of iron deficiency (in combination with ferritin)?
What else would you consider in your differential?
Would it change your management if the thrombus was symptomatic? Or if larger >3 cm?
For example, a patient with a bone marrow biopsy that shows normocellular bone marrow. Prior management with leflunomide and HCQ with neutropenia attr...
If so, what platelet count threshold would you use? Would age impact your decision? Would you do a bone marrow to rule out primary MPD in adults if th...
In the absence of concerning bleeding or thrombosis, family history of coagulopathy, current anticoagulant use, or malnutrition
What are indications to order gene mutation studies (e.g. ELANE) and how would it help the patient?
Increased genomic testing is likely to increase the frequency with which we encounter these mutations, which we might not otherwise have tested for. H...
Ferritin uptrending >1000, no additional lab abnormalities. HFE wildtype. Too young for age-appropriate cancer screening. Asymptomatic except fatig...
Is thrombotic risk too significant? Patient failed OCPs.
For example, if TSAT is less than 20% but ferritin is over 200.
CRP 39 mg/L (normal < 10) and normal ESR
APLA syndrome, obesity, non compliance ruled out and prefers another oral anticoagulation. Is higher dose of rivaroxaban or apixaban an option?
Should we stop checking factor VIII levels as part of thrombosis workup?
(e.g. beta 2 glycoprotein IgM > 20 but <40)
Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?
IVIG, TPO, or other agents?
What should be done with a high level?
Is there a particular sequence you would adjust contributing antirejection or antimicrobial medications? Is the use of G-CSF appropriate and at what c...
Have you used anticoagulants other than coumadin? Or is that the only appropriate agent given monitoring is based on PT/INR?
There are multiple difficulties that could be seen: steroids can precipitate a sickle cell crisis, vasculitis and sickle cell can produce similar clin...
Does transplant eligibility make a difference for management?
Is there a role for empiric antibiotics if there is history of opportunistic infection?
Such as a patient who cannot tolerate oral iron and has had a anaphylaxis to intravenous iron
For example, a patient with hypogonadism unless it matters which organ is involved. Are other markers of iron storage useful in guiding therapy?
If autoimmune neutropenia already suspected, is this test informative or unnecessary?
What is the lowest level you have seen with uncomplicated or complicated crises?
Do you go straight to TMPRSS2 genetic testing or what other lab testing (e.g. hepcidin) could be helpful?
Is there a preferred strategy of transfusional support versus reduced-dose anticoagulation during the duration of thrombocytopenia?
What if this was "triple-negative" antiphospholipid syndrome?
Does your opinion change based on the specific underlying inherited thrombophilia? The original case was a central retinal artery occlusion in a patie...
2589625218198152338922378210131631220941206381964420362194381681617061172191042318671182698580157611330014914129101329117970178981716517434172811709617109117861564415940161281408113479148921244915022131601475913999143411404913968139021352013453128471326212952129141280612787122671216111567117981156911152812510930108551055210450103411022099639040893786438911866486408635811480347235
Papers discussed in this category
Blood,
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2016-04
Blood, 2018 Jul 12
Ann. Intern. Med., 2019 Oct 15
Blood Transfus, 2018 Oct 24
J Thromb Haemost, 2018 May 08
American journal of hematology, 2011-10
The American journal of medicine, 2017-12
American journal of hematology, 2018-05
Am J Hematol, 2020 Jun 29
Am J Hematol, 2019 Sep
Am J Hematol, 2019 Sep
Am J Hematol, 2018 Jun
JAMA,
N Engl J Med,
American journal of hematology, 2008-08
Blood, 2010-07-22
Am J Gastroenterol,
Rheumatol Int, 2019 Apr 30
Clin Exp Rheumatol, 2012 Sep 25
Wien Klin Wochenschr,
J Rheumatol, 2006 Jul 01
Semin Arthritis Rheum,
Seminars in hematology, 2013-07
Ann Oncol, 2021 Mar 18
Blood, 2016-07-14
Blood, 2016 Sep 26
Blood Adv, 2020 Jan 28
Blood, 2019 Apr 25
Circulation, 2022 Nov 06
Circulation, 2022 Nov 06
Lupus, 2021 May 27
Genetic epidemiology, 2016-09
American journal of hematology, 2019-03
Blood, 2021 Jan 07
Blood, 2013-08-01
Circulation, 2003 Jun 17
Haematologica, 2007 Feb
PLoS One, 2015 Dec 30
Int J Lab Hematol, 2021 Oct 05
Blood, 2003 Mar 27
N Engl J Med, 2019 Sep 19
Am J Med, 1990 Mar
Hepatology, 1996 Jun
Hepatology, 1986 Jul-Aug
Gut, 1992 Jan
Seminars in hematology, 2002-04
Blood, 2002 Jan 01
Blood advances, 2024 Aug 13
Annals of oncology : official journal of the European Society for Medical Oncology, 2018 Sep 01
Journal of pharmacy practice, 2021 Nov 08
The New England journal of medicine, 1994-03-17
Haematologica, 2013-09
Journal of medical case reports, 2014 Mar 04
JAMA, 2023 Aug 8
Blood, 2017 Jan 31
European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 2021 Dec 06
Blood, 1998-01-01
Blood advances, 2020 Apr 28
Journal of thrombosis and haemostasis : JTH, 2020 Nov
Journal of thrombosis and haemostasis : JTH, 2023 Aug 18
Blood advances, 2023 Nov 28
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2024 Aug 08